Abstract:Background Re-capture of the differences between tumor and normal tissues observed at the patient level in cell cultures and animal models is critical for applications of these cancer-related differences. The epithelial-mesenchymal transition (EMT) process is essential for tumor migratory and invasive capabilities. Although plenty of EMT markers are revealed, molecular features during the early stages of EMT are poorly understood. Methods A cell-based model to induce lung cell (A549) EMT using conditioned medium of in vitro cancer activated fibroblast (WI38) was established. High-throughput sequencing methods, including RNA-seq and miRNA-seq, and advanced bioinformatics methods were used to explore the transcriptome profile transitions accompanying the progression of EMT. We validated our findings with experimental techniques including transwell and immunofluorescence assay, as well as the TCGA data. Results We have constructed an in vitro cell model to mimic the EMT in patients. We discovered that several new transcription factors were among the early genes (3 h) to respond to cancer micro-environmental cues which could play critical roles in triggering further EMT signals. The early EMT markers also included genes encoding membrane transporters and blood coagulation function. Three of the nine-examined early EMT hallmark genes, GALNT6, SPARC and HES7, were up-regulated specifically in the early stages of lung adenocarcinoma (LUAD) and confirmed by TCGA patient transcriptome data. In addition, we showed that miR-3613, a regulator of EGFR pathway genes, was constantly repressed during EMT progress and indicative of an epithelial miRNA marker. Conclusions The CAF-stimulated EMT cell model may recapture some of the molecular changes during EMT progression in clinical patients. The identified early EMT hallmark genes GALNT6, SPARC and HES7and miR-3613 provide new markers and therapeutic targets for LUAD for the further clinical diagnosis and drug screening.

EMT transcription factors activated circuits: A novel tool to study EMT dynamics and its therapeutic implications

Optogenetic control of epithelial-mesenchymal transition in cancer cells

Quantifying the landscape and kinetic paths for epithelial-mesenchymal transition from a core circuit.

Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing

Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities

Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer

Epithelial-mesenchymal Transition Markers Screened in a Cell-Based Model and Validated in Lung Adenocarcinoma

AKT-ions with a TWIST between EMT and MET.

Tracking epithelial-mesenchymal transition in breast cancer cells based on a multiplex electrochemical immunosensor

Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition

Mechanotactic Activation of TGF‐β by PEDOT Artificial Microenvironments Triggers Epithelial to Mesenchymal Transition

Multiplex Sensing of Biomarkers on the Cancer Cell Surface by an Epithelial-Mesenchymal Transition (EMT) Sensing Panel Enables Precise Differentiating of Cancer Cells at Various EMT Stages

Coupled Reversible and Irreversible Bistable Switches Underlying TGF-β-induced Epithelial to Mesenchymal Transition

Toward Modeling Context-Specific EMT Regulatory Networks Using Temporal Single Cell RNA-Seq Data

dbEMT 2.0: an updated database for epithelial-mesenchymal transition genes with experimentally verified information and pre-calculated regulation information for cancer metastasis

EMT-activating Transcription Factors in Cancer: Beyond EMT and Tumor Invasiveness.

A possible role for epigenetic feedback regulation in the dynamics of the epithelial–mesenchymal transition (EMT)

Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds

Hysteresis Control of Epithelial-Mesenchymal Transition Dynamics Conveys a Distinct Program with Enhanced Metastatic Ability

Reconstruction of single cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition

Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions